In recent years, with the development of next generation sequencing (NGS) and other technologies, deep sequencing and single cell sequencing technologies have flourished, and the implementation of the Global Tumor Genome Project and the completion of The Cancer Genome Atlas (TCGA) have created favorable conditions for efficient and accurate personalized sequencing of patients. Currently,...